Published on in Vol 5 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/60853, first published .
Peer Review of “Machine Learning–Based Hyperglycemia Prediction: Enhancing Risk Assessment in a Cohort of Undiagnosed Individuals”

Peer Review of “Machine Learning–Based Hyperglycemia Prediction: Enhancing Risk Assessment in a Cohort of Undiagnosed Individuals”

Peer Review of “Machine Learning–Based Hyperglycemia Prediction: Enhancing Risk Assessment in a Cohort of Undiagnosed Individuals”

Authors of this article:

Akhil Chaturvedi1 Author Orcid Image


This is the peer-review report for “Machine Learning–Based Hyperglycemia Prediction: Enhancing Risk Assessment in a Cohort of Undiagnosed Individuals.”


General Comments

Overall strong paper [1]! This was an interesting study on the use of machine learning to predict hyperglycemia in a cohort of undiagnosed individuals from Nigeria. I feel like this work is a strong contribution to the field of public health, especially within the context of noncommunicable diseases in developing countries. I also like that it is backed well with quantitative methods. The strengths of this manuscript lie in its detailed methodology and its comprehensive data analysis.

Specific Comments

Major Comments
  • While the study demonstrates a robust analytical approach, it would benefit from external validation with an independent dataset. This would strengthen the findings and ensure the model’s generalizability and applicability in different populations.
  • The manuscript could be improved by providing more context on the selection of the machine learning algorithms used in the study. An explanation of why certain algorithms were chosen and others potentially excluded would offer clarity.
Minor Comments
  • The manuscript occasionally uses technical jargon that might not be easily understandable to readers not familiar with machine learning. Simplifying the language or providing brief explanations will make the paper more accessible.
  • The study’s potential for real-world application would be clearer with a section on future work, detailing how these algorithms could be deployed in clinical settings or used in larger-scale studies (I can see how this might be a tangential research direction, but this would still be great given the potential impact).

Based on this, my recommendation is:

A: Accept

Conflicts of Interest

None declared.

  1. Oyebola K, Ligali F, Owoloye A, et al. Machine learning–based hyperglycemia prediction: enhancing risk assessment in a cohort of undiagnosed individuals. JMIRx Med. 2024;5:e56993. [CrossRef]

Edited by Edward Meinert; This is a non–peer-reviewed article. submitted 23.05.24; accepted 23.05.24; published 11.09.24.

Copyright

© Akhil Chaturvedi. Originally published in JMIRx Med (https://med.jmirx.org), 11.9.2024.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIRx Med, is properly cited. The complete bibliographic information, a link to the original publication on https://med.jmirx.org/, as well as this copyright and license information must be included.